(Amherst, NH) - Until recently and with a few notable exceptions, administering drugs by injection has fallen within the province of professional care givers. But as patients live longer and are diagnosed with chronic and often debilitating ailments, the result will be a dramatic increase in self-administration of drug therapies in non-traditional settings for a number of conditions. This trend is creating an increased interest in routes of administration that are patient-friendly and cost-effective.

Population demographics and efforts by managed care providers to control healthcare costs are driving the growth in drug self-administration, particularly for chronic conditions, introducing a new class of naïve users to parenteral drug delivery. User-friendly syringe and injection device designs and the availability of an increasing number of drugs in pre-filled insertable and disposable cartridges are propelling the growth of prefilled syringes for self-administration.

These findings are contained in a new and comprehensive report, Injectable Drug Delivery: Evolving Markets, Emerging Opportunities. Growth of injectable drugs for chronic conditions will be driven by a number of factors, including improved patient compliance and patient quality-of-care, and the trend toward drug therapy self-administration.
More information is available at www.greystoneassociates.org .

About Greystone

Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology and market assessment.

Contact:
Mark Smith
Voice: 603-595-4340
Fax: 603-804-0466
www.greystoneassociates.org
Source: Greystone Associates